HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dennis G McGonagle Selected Research

Dennis G McGonagle Research Topics

Disease

6Psoriatic Arthritis
01/2023 - 09/2013
5COVID-19
01/2022 - 01/2021
5Inflammation (Inflammations)
01/2021 - 07/2008
3Rheumatoid Arthritis
12/2023 - 12/2014
3Necrosis
01/2020 - 01/2019
2Arthralgia (Joint Pain)
12/2023 - 01/2018
2Arthritis (Polyarthritis)
12/2023 - 01/2020
2Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023 - 01/2020
2Synovitis
01/2022 - 01/2018
2Ankylosing Spondylitis
01/2019 - 09/2013
2Axial Spondyloarthritis
01/2019 - 09/2013
2Edema (Dropsy)
09/2013 - 07/2008
1Asthma (Bronchial Asthma)
12/2023
1Uveitis
01/2023
1Osteoarthritis
01/2022
1Infections
01/2021
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2020
1Adult-Onset Still's Disease
01/2020
1Pneumocystis Infections
01/2020
1Spondylarthropathies
01/2019
1Nail Diseases (Nail Disease)
01/2018
1Enthesopathy
01/2018
1Pain (Aches)
01/2018
1Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
04/2016
1Lymphoma (Lymphomas)
12/2014
1Fibrosis (Cirrhosis)
11/2013
1Muscular Diseases (Myopathy)
02/2012
1Joint Diseases (Joint Disease)
12/2007

Drug/Important Bio-Agent (IBA)

4InterleukinsIBA
12/2023 - 01/2019
4GlucocorticoidsIBA
01/2022 - 01/2020
3Immunologic Factors (Immunomodulators)IBA
01/2022 - 01/2021
3baricitinibIBA
01/2022 - 01/2020
3Biomarkers (Surrogate Marker)IBA
01/2022 - 07/2008
2tocilizumab (atlizumab)FDA Link
01/2022 - 10/2021
2tofacitinibIBA
01/2022 - 10/2021
2Antirheumatic Agents (DMARD)IBA
01/2022 - 01/2020
2Janus Kinase InhibitorsIBA
01/2022 - 10/2021
2Oxygen (Dioxygen)IBA
01/2022 - 01/2021
2Immunomodulating AgentsIBA
10/2021 - 01/2021
2CytokinesIBA
01/2021 - 01/2019
2AntibodiesIBA
01/2021 - 02/2012
2Interleukin-23 (Interleukin 23)IBA
01/2020 - 11/2019
1benralizumabIBA
12/2023
1Anti-Citrullinated Protein AntibodiesIBA
12/2023
1Acute-Phase Proteins (Acute-Phase Protein)IBA
12/2023
1mepolizumabIBA
12/2023
1Rheumatoid FactorIBA
12/2023
1Histocompatibility Antigens Class IIBA
01/2023
1AminopeptidasesIBA
01/2023
1Indicators and Reagents (Reagents)IBA
01/2022
1Interleukin-1 (Interleukin 1)IBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
01/2021
1InterferonsIBA
01/2021
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2021
1apremilastIBA
01/2020
1Janus Kinase 1IBA
01/2020
1amsonic acid (DAS)IBA
01/2020
1Interleukin-12 (IL 12)IBA
01/2020
1guselkumabIBA
01/2020
1Interleukin-17 (Interleukin 17)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Tumor Necrosis Factor InhibitorsIBA
01/2018
1SteroidsIBA
04/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2014
1HLA-B27 Antigen (HLA B27 Antigen)IBA
09/2013
1Cholinergic ReceptorsIBA
02/2012

Therapy/Procedure

7Therapeutics
12/2023 - 12/2007
5Immunomodulation
01/2022 - 01/2021
1Transplantation
01/2023
1Knee Replacement Arthroplasty (Total Knee Replacement)
01/2022
1Injections
01/2020
1Biological Therapy
01/2018